PortalPublikationen[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and halluc...

[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]

Standard

[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]. / Thomasius, R; Gouzoulis-Mayfrank, E; Karus, C; Wiedenmann, H; Hermle, L; Sack, P M; Zeichner, D; Küstner, U; Schindler, Andreas; Krüger, A; Uhlmann, S; Petersen, K U; Zapletalova, P; Wartberg, L; Schütz, C G; Schulte-Markwort, M; Obrocki, J; Heinz, A; Schmoldt, A.

in: FORTSCHR NEUROL PSYC, Jahrgang 72, Nr. 12, 12, 2004, S. 679-695.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Thomasius, R, Gouzoulis-Mayfrank, E, Karus, C, Wiedenmann, H, Hermle, L, Sack, PM, Zeichner, D, Küstner, U, Schindler, A, Krüger, A, Uhlmann, S, Petersen, KU, Zapletalova, P, Wartberg, L, Schütz, CG, Schulte-Markwort, M, Obrocki, J, Heinz, A & Schmoldt, A 2004, '[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]', FORTSCHR NEUROL PSYC, Jg. 72, Nr. 12, 12, S. 679-695. <http://www.ncbi.nlm.nih.gov/pubmed/15580533?dopt=Citation>

APA

Thomasius, R., Gouzoulis-Mayfrank, E., Karus, C., Wiedenmann, H., Hermle, L., Sack, P. M., Zeichner, D., Küstner, U., Schindler, A., Krüger, A., Uhlmann, S., Petersen, K. U., Zapletalova, P., Wartberg, L., Schütz, C. G., Schulte-Markwort, M., Obrocki, J., Heinz, A., & Schmoldt, A. (2004). [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]. FORTSCHR NEUROL PSYC, 72(12), 679-695. [12]. http://www.ncbi.nlm.nih.gov/pubmed/15580533?dopt=Citation

Vancouver

Thomasius R, Gouzoulis-Mayfrank E, Karus C, Wiedenmann H, Hermle L, Sack PM et al. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]. FORTSCHR NEUROL PSYC. 2004;72(12):679-695. 12.

Bibtex

@article{b4d746acb4524a0a8968b654203f0fbf,
title = "[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]",
abstract = "Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.",
author = "R Thomasius and E Gouzoulis-Mayfrank and C Karus and H Wiedenmann and L Hermle and Sack, {P M} and D Zeichner and U K{\"u}stner and Andreas Schindler and A Kr{\"u}ger and S Uhlmann and Petersen, {K U} and P Zapletalova and L Wartberg and Sch{\"u}tz, {C G} and M Schulte-Markwort and J Obrocki and A Heinz and A Schmoldt",
year = "2004",
language = "Deutsch",
volume = "72",
pages = "679--695",
journal = "FORTSCHR NEUROL PSYC",
issn = "0720-4299",
publisher = "Georg Thieme Verlag KG",
number = "12",

}

RIS

TY - JOUR

T1 - [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]

AU - Thomasius, R

AU - Gouzoulis-Mayfrank, E

AU - Karus, C

AU - Wiedenmann, H

AU - Hermle, L

AU - Sack, P M

AU - Zeichner, D

AU - Küstner, U

AU - Schindler, Andreas

AU - Krüger, A

AU - Uhlmann, S

AU - Petersen, K U

AU - Zapletalova, P

AU - Wartberg, L

AU - Schütz, C G

AU - Schulte-Markwort, M

AU - Obrocki, J

AU - Heinz, A

AU - Schmoldt, A

PY - 2004

Y1 - 2004

N2 - Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.

AB - Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.

M3 - SCORING: Zeitschriftenaufsatz

VL - 72

SP - 679

EP - 695

JO - FORTSCHR NEUROL PSYC

JF - FORTSCHR NEUROL PSYC

SN - 0720-4299

IS - 12

M1 - 12

ER -